You find a spot on your skin that is causing suspicion. It might be a scab that’s been there for too long, an ingrown hair, or a sunspot you’re just not sure about. So, you go in to see your dermatologist, as you should with anything remotely concerning on your skin. Your dermatologist will take […]
Sensus Healthcare Announces Publication of Research on Long-term Efficacy and Safety of Superficial Radio Therapy in Journal of Drugs in Dermatology
Retrospective registry study showed a 98.9% non-recurrence rate after 85 months in subjects with non-melanoma skin cancer treated with SRT BOCA RATON, Fla. , March 03, 2020 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, today announced that results […]
The Prevalence of Skin Cancer in Transplant Patients
Skin cancer is the most common cancer found in organ transplant recipients. Patients who have received organ transplants are at risk of developing skin cancer. Specifically, 65% more likely than people without transplants. Moreover, in a study conducted by the International Transplant Skin Cancer Collaborative (ITSCC), it was found that transplant patients have a 100-fold […]
States With The Highest Risk for Melanoma
This is taken from an article posted on CNN.com written by Shelby Lin Erdman dated 02/18/2020: (CNN) – States with the highest rates of melanoma cases linked to ultraviolet radiation are spread across the United States on the East and West coasts, in Hawaii and in landlocked states, according to a study published Monday in […]
Non-Melanoma Skin Cancer Outcomes
Dr. William Roth presents three cases of non-melanoma skin cancer being treated by Superficial Radio Therapy (SRT). Look at these amazing results!
Keloid Patient Testimonials
Hear from the patients themselves! These individuals had their keloids treated with SRT and have achieved amazing results.
Non-Melanoma Skin Cancer Patient Testimonials
Hear from the patients themselves! These individuals had their non-melanoma skin cancer treated with SRT and have achieved amazing results.
Sensus Healthcare Reports Fourth Quarter and Full Year 2019 Financial Results
Fourth quarter net income up 10-fold to $1.0 million, diluted EPS of $0.06 Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., Feb. 13, 2020 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces financial results […]
Sensus Healthcare to Host Fourth Quarter 2019 Financial Results and Business Update Conference Call on February 13, 2020
BOCA RATON, Fla. , Feb. 06, 2020 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Thursday, February 13, 2020 at 4:30 p.m. Eastern time to discuss the financial results for the fourth […]
What are the Causes of Keloids?
Keloids are a type of scar composed of collagen. They can be firm or rubbery with a shiny, brown or pink appearance. Although sometimes painful or itchy, they usually pose no threat to your overall health and are not contagious. Keloids are more prevalent in individuals of African, Asian, or Hispanic descent, though anyone can […]
Restore Your Patients’ Confidence with SRT for Keloid Scars
The Issue with Keloid Scars Keloid scars affect 18 million people, and many of them go through life believing that treatment for their embarrassing and sometimes painful scarring is impossible or even non-existent. Thick, unsightly keloid scars can significantly affect an individual’s confidence, but with the SRT-100™, you can help them gain it back. Restore […]
Sensus Healthcare Announces Sculptura™ Shipment to California-based Medical Center Third Sculptura system sold worldwide
BOCA RATON, Fla, Jan. 22, 2020 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, is pleased to announce it has shipped and installed a Sculptura™ radiation oncology system to Stanford Health Care in Palo Alto, Calif. The system was […]
What Your Patients Should Know About Childhood Skin Cancer
September is Childhood Cancer Awareness month, a campaign to spotlight the types of cancer that largely affect children, draw attention to survivorship issues and raise funds for research and family support. In the US, more than 15,000 children aged younger than 21 years are diagnosed with cancer every year. Of those, the National Cancer Institute […]
Non-Melanoma Skin Cancer & What You Probably Did Not Know
Non-melanoma skin cancer has reportedly increased “33% since 2012” (Practical Dermatology, September 2019). For these skin cancer-related cases, there was reportedly “3.5 million total procedures in 2018… 3.35 million being for non-melanoma skin cancer” (Practical Dermatology, September 2019). With these increasing numbers, persons are turning to their local physicians for skin cancer checks. What physicians […]
Sensus Healthcare Announces Management Promotions
New corporate structure positions company for 2020 financial goals BOCA RATON, Fla., Jan. 06, 2020 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces management promotions to better support the company’s financial goals for profitability in 2020 and beyond. […]
85.6% Cure Rate for Keloids Treated by SRT Post Surgery
Those who suffer from keloid scarring are often left wondering what they can do to finally get rid of their keloids for good. Superficial Radio Therapy is quickly becoming a popular solution to treat keloids after surgical removal. A retrospective study from early 2019 shows that there is an 85.6% cure rate for keloids using […]
Battling Skin Cancer? Look No Further than the Non-Surgical SRT-100™ for Your Squamous Cell Carcinoma Treatment
Squamous cell carcinoma is the second most common type of skin cancer. There are more than 700,000 new cases diagnosed each year in the United States. Fortunately, there is a new Squamous Cell Carcinoma Treatment available through Sensus Healthcare – The SRT-100™. What is Squamous Cell Carcinoma? Squamous cell carcinoma develops in the thin, flat […]
SRT-100™: Cure Your Patients with This Revolutionary Non-Surgical Squamous Cell Carcinoma Treatment
Each year, there are more new cases of skin cancer than the combined incidence of cancers of the breast, prostate and colon. Nearly four million people in the United States will be diagnosed with basal cell or squamous cell carcinoma this year, with an estimated 700,000 of those cases diagnosed as squamous cell carcinoma. Squamous […]
Sensus Healthcare to Present at the Piper Jaffray 31st Annual Healthcare Conference
BOCA RATON, Fla., Nov. 21, 2019 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announced today that Joe Sardano, CEO of the Company, will present a corporate overview at the Piper Jaffray 31st Annual Healthcare Conference on Thursday, December […]
Sensus Healthcare Reports Third Quarter 2019 Financial Results
Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., Nov. 06, 2019 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces financial results for the three and nine months ended September 30, 2019. Highlights from the […]